16 August 2021: Clinical Research
Association Between Serum Albumin Levels and Obesity and Risk of Developing Chronic Kidney Disease Using Data from the Korean Multi-Rural Communities Cohort (MRCohort) Population Database
Kwang Ho Mun ABCDEFG*DOI: 10.12659/MSM.933840
Med Sci Monit 2021; 27:e933840
Table 4 Hazard ratios of chronic kidney disease development according to albumin and obesity.
| G2HR (95% CI) | p | G3HR (95% CI) | p | G4HR (95% CI) | p | |
|---|---|---|---|---|---|---|
| Model 1 | 1.20 (0.54–2.61) | NS | 1.94 (0.98–3.82) | NS | 2.42 (1.25–4.68) | |
| Model 2 | 1.69 (0.76–3.75) | NS | 1.55 (0.77–3.13) | NS | 2.70 (1.37–5.30) | |
| Model 3 | 1.68 (0.76–3.75) | NS | 1.54 (0.76–3.11) | NS | 2.66 (1.35–5.24) | |
| Model 1: not adjusted; Model 2: adjusted for age (by 10 years), sex, body mass index, smoking, alcohol, exercise, systolic blood pressure, diastolic blood pressure, glucose, total cholesterol, triglyceride, high-density lipoprotein, aspartate aminotransferase, alanine aminotransferase and γ-glutamyl transpeptidase; Model 3: Model 2+calorie and protein (by recommended amount). Albumin levels were studied by albumin quartiles (Q1–4), with lowest group (Q1) as reference. HR – hazard ratio; NS – not significant. | ||||||